POMICELL

AI-based Personalized Disease Models

Health Tech & Life Sciences
Non Active, Jun 2024 ceased to operate
Pre-Seed Jerusalem, Israel Founded 2016
LinkedIn
Last updated 2026-06-18
Total raised
$4.0M
Last: Grant 2019-01
Stage
Pre-Seed
Founded
2016
Headcount
5
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Pomicell is the developer of POMI, a revolutionary AI SaaS solution that enables researchers in the biomedical field to enhance R&D processes with a quick, easy, three-click AI model creator.

The core AI-based capabilities offered by Pomicell’s platform include automatic disease treatment, big data modeling, automatic mechanism of action, hypothesis creation from literature, and a medical record-enhanced mechanism of action deciphering.

The company’s mission is to provide advanced digital tools aimed at enhancing personalized medicine by helping physicians quickly accelerate research and better understand their patients.

Funding history · 3 rounds · $4.0M total

2019-01
2017-01
Date unknown

Q&A

What is POMICELL's current operational status?
POMICELL is currently inactive, having ceased operations in June 2024.
What is POMICELL's primary focus?
POMICELL focuses on Health Tech & Life Sciences, developing an AI-based SaaS solution for personalized disease models to enhance R&D processes in the biomedical field.
When was POMICELL founded?
POMICELL was founded in October 2016.
How much funding has POMICELL raised in total?
POMICELL has raised a total of $4,000,000 USD.
Who was a lead investor in POMICELL's January 2019 grant round?
In January 2019, POMICELL received a grant from the Israel Innovation Authority.
Who is the Founder & CEO of POMICELL?
Boaz Buchandler is the Founder & CEO of POMICELL.
What technologies does POMICELL utilize?
POMICELL utilizes Artificial Intelligence, Machine Learning, and Natural Language Processing.

Team · 1

Boaz Buchandler
Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Artificial IntelligenceMachine LearningNatural Language Processing
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

machine-learningdata-analyticsnatural-language-processingpersonalizationlaboratoriesacademiabig-data-analyticsartificial-intelligencedigital-healthcaremedical-technologiesdermatologypharma-companiescancerdecision-supportsoftware-platform
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)